Cartesian Therapeutics Inc. (RNAC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cartesian Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$6.69
+3.56% today
Market cap
$195M
Overall quality
—
Kronos AI 30-day
+25.6%
8 of 8 simulated paths end higher
Cartesian Therapeutics Inc. (RNAC) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $195M. It trades at $6.69, up 3.56% today. 6 analysts' average target of $32.60 implies +387.3% from today's price. Kronos AI's 30-day forecast is +25.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $32.60 |
| Low – high | $16.00 – $44.00 |
| Analysts | 6 |
| Upside to average | +387.3% |
Kronos AI 30-day forecast
| Expected close | $8.11 (+25.6%) |
| Likely range | +19.2% … +32.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.